Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Feb 11;18(13):2945–2951.e1. doi: 10.1016/j.cgh.2020.01.045

Table 1:

Baseline characteristics and healthcare utilization by patients with IBS

Demographic characteristics
Mean age (SD) 44.1 (17.0)
Female gender 107 (78.1%)

Clinical characteristics N (%)
IBS subtype
 IBS-D 38 (27.7)
 IBS-C 69 (50.4)
 IBS-M 30 (21.9)
Mean IBS symptom severity* 266.1 (100.9)
Baseline characteristics** N (%)
Anxiety 48 (35)
Depression 23 (16.8)
Sleep disturbance 35 (25.6)
Prior gastroenterology consultation 107 (78.1)
Duration of symptoms
 < 1 year 16 (11.7)
 1–5 years 27 (19.7)
 5–10 years 17 (12.4)
 >10 years 77 (56.2)
Healthcare utilization in three months after initial consultation
Serological or stool investigations performed 76 (55.5)
Median number of diagnostic tests performed*** 1 (0–4)
Median number of medications taking for their GI symptoms**** 2 (0–10)
Median number of recommendations at initial visit***** 4 (1–10)
Median number of phone calls 0 (0–9)
Median number of follow-up visits 1 (0–4)
Median number of services referred to 0 (0–2)
Physician characteristics
Patients evaluated by female physician 101(73.7)
Patients evaluated by Fellows at first visit 51 (37.2)

Mean values are expressed with standard deviation (SD) and median values with range.

*

Measured using IBS-SSS

**

Defined by PROMIS T-score ≥60

***

Includes endoscopies, manometries, breath tests, and radiologic investigations

****

Includes over the counter as well as prescription

*****

Includes pharmacological and non-pharmacological therapies, referrals, lifestyle changes